Eli Lilly and Company - FDA Approves Cymbalta for the Management of Chronic Musculoskeletal Pain
Links shared publicly online about this topic.
- 749total visits
Eli Lilly and Company - FDA Approves Cymbalta for the Management of Chronic Musculoskeletal Pain
Eli Lilly and Company - FDA Approves Cymbalta for the Management of Chronic Musculoskeletal Pain
View full resource at newsroom.lilly.com
Tags: Anxiety Medication, Antidepressant, Musculoskeletal, Fibromyalgia Medication, Neuropathic Pain Medication, FDA, Cymbalta
Most Recently Shared on November 5, 2010 at 1:41 pm By:
FDA Approves Cymbalta® for the Management of Chronic Musculoskeletal Pain - http://ow.ly/34Xyu
Advertisement
